Diagnostic concordance of pathological methods and reports ofhematopathologists compared to local nonspecialized pathologists in thediagnosis of lymphoma in Mexico
The adequate medical management of patients withhematological neoplasms requires a thorough andaccurate histopathological diagnosis. In 1994, theRevised European American Classification of Lympho-mas proposed the incorporation of objective criteria,such as morphology...
Hematopoietic stem cell transplantation activity in Mexico during the COVID19pandemic: on the way to recovery
Hematopoietic stem cell transplantation (HSCT) is aneffective treatment for many patients with hemato-poietic disorders [1]. HSCT is a complex and costly pro-cedure that impacts health systems and patients socioeconomic well-being.
Síndrome de fuga aérea torácica por enfermedad de injerto contra huésped posterior a trasplante alogénico de médula ósea
Actualmente, el trasplante de precursores hematopoyéticos es el tratamiento en neoplasias hematológicas. La enfermedad injerto contra huésped es una complicación de la introducción de dichas células. Las afecciones pulmonares son frecuentes, dentro de ellas se encuentra el síndrome de fuga aérea torácica.
What is the Evidence of Lymphoma in Patients with Prostheses Other Than Breast Implants?
Medical devices such as hip, knee, breast, vascular prostheses, among others, are very useful in different pathologies. We cannot doubt that their use is a great tool, besides being an advance in medicine; they provide a change in the quality of life of many patients; however, they are not exempt from adverse reactions and events.
Manuel Solano-Genesta, Luz Tarín-Arzaga, Ileana Velasco-Ruiz, David Gómez-Almaguer,
et al. CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic value. Hematology 2012; 17(2): 66-70.
Gutiérrez-Aguirre CH, Cantú-Rodríguez OG, Borjas-Almaguer OD, González-Llano O,
Jaime-Pérez JC, Solano-Genesta M, Gómez-Guijosa M, Mancias-Guerra C, Tarin L, and Gómez-Almaguer D.
Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapyfor steroid-resistant chronic graft-versus -host disease. Haematologica 2012;97(5):717-722
Gomez-AlmaguerD, Solano-Genesta M, Tarin-Arzaga L, et.al. Low-dose
rituximab and alemtuzumab combination therapy for patients with steroidrefractory autoimmune cytopenias. Blood. 2010;116(23):4783-4785.
Solano-Genesta M, Tarin-Arzaga L, Cantú-Rodríguez OG,
et.al. Trasplante alogénico de células tallo con acondicionamiento de intensidad reducida en pacientes de edad avanzada, el método mexicano. Experiencia de un centro hospitalario del Noreste de México. Rev Hematol Mex 2010;11(4):188-192. Solano-Genesta M. et al. Linfocitopenia selectiva de CD4 Idiopática: Reporte de un caso y revisión de la Literatura. Anales Médicos 2009; 54(2): 97-99.